| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 243.08B | 259.05B | 240.34B | 229.71B | 212.04B | 172.74B |
| Gross Profit | 100.13B | 105.28B | 95.57B | 88.21B | 78.51B | 69.45B |
| EBITDA | 23.82B | 26.45B | 23.95B | 20.60B | 15.80B | 12.74B |
| Net Income | 14.99B | 18.38B | 15.24B | 14.31B | 9.91B | 7.72B |
Balance Sheet | ||||||
| Total Assets | 214.91B | 251.47B | 218.48B | 206.15B | 197.52B | 166.36B |
| Cash, Cash Equivalents and Short-Term Investments | 35.99B | 46.02B | 32.40B | 31.96B | 23.84B | 24.43B |
| Total Debt | 12.99B | 25.11B | 16.60B | 13.40B | 24.81B | 11.21B |
| Total Liabilities | 57.82B | 77.19B | 61.35B | 64.08B | 73.24B | 53.89B |
| Stockholders Equity | 156.30B | 173.36B | 156.35B | 141.45B | 123.74B | 111.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.58B | 3.73B | 20.11B | -12.43B | 10.14B |
| Operating Cash Flow | 0.00 | 17.31B | 7.01B | 21.41B | -8.05B | 12.04B |
| Investing Cash Flow | 0.00 | -5.28B | -3.51B | 131.00M | -4.45B | -2.18B |
| Financing Cash Flow | 0.00 | 1.10B | -4.01B | -14.01B | 11.01B | -8.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥879.80B | 18.27 | 49.14% | 2.82% | 7.15% | 6.34% | |
68 Neutral | ¥258.17B | 13.60 | 10.61% | 1.81% | 7.78% | 20.67% | |
63 Neutral | ¥76.15B | 15.69 | ― | 2.11% | 4.97% | -22.34% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥46.78B | -20.24 | ― | 3.31% | 0.69% | -377.37% | |
46 Neutral | ¥1.62T | -13.15 | -21.14% | ― | 10.70% | 36.82% | |
43 Neutral | ¥10.36B | -50.67 | ― | 3.08% | 2.51% | -235.45% |